Sex Transm Dis. 2018 Feb;45(2):132-137. doi: 10.1097/OLQ.0000000000000706. BACKGROUND: Chlamydia trachomatis is a common, often recurring sexually transmitted infection, with serious adverse outcomes in women. Current guidelines recommend retesting after a chlamydia infection, but the optimum timing is unknown. We assessed the optimal retest interval after urogenital chlamydia treatment. METHODS:...
aidsmap/nam, 25 October 2016
SImplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).
Read more here
Dr Jennifer Gunter, September 10 2016 The Mirena intrauterine system (IUS), the IUD with the hormone levonorgestrel, is a highly effective method of contraception currently approved for five years. Some data suggests that it probably good for six years, but a new study tells us with a good degree of confidence that the Mirena is safe and effective for seven years. The study was funded by UNDP/...
BMJ 2016; 352 doi: (Published 19 January 2016) What is already known on this topic Patients’ preferences are a hallmark of patient centered care, but little is known about how wording of offers of testing can influence perceived preferences Opt-in and opt-out HIV testing have not been compared in a randomized controlled setting US guidelines endorse opt-out HIV testing, and Europe has seen a...
Sex Transm Infect 2015;91:106-110 doi:10.1136/sextrans-2014-051719
Background: Uptake of chlamydia screening by men in England has been substantially lower than by women. Non-traditional settings such as sports clubs offer opportunities to widen access. Involving people who are not medically trained to promote screening could optimise acceptability.
Read abstract here
Read full text here